CSL shares are down 10 per cent year-to-date, but stock watchers see growth ahead for the listed biotech giant on the horizon.
Brisbane Times – Business
CSL shares are down 10 per cent year-to-date, but stock watchers see growth ahead for the listed biotech giant on the horizon.
Brisbane Times – Business